FDA orphan drug designation: treatment of Charcot-Marie-Tooth (CMT) disease
All entries for: Augustine Therapeutics NV
August 13, 2025
Augustine Therapeutics NV
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of Charcot-Marie-Tooth (CMT) disease
